|
GB2101114B
(en)
|
1981-07-10 |
1985-05-22 |
Farmos Group Ltd |
Substituted imidazole derivatives and their preparation and use
|
|
JPS60163811A
(ja)
|
1984-02-06 |
1985-08-26 |
Watanabe Yakuhin Kogyo Kk |
プロプラノロ−ル含有外用貼付剤
|
|
FI844786A0
(fi)
|
1984-12-04 |
1984-12-04 |
Farmos Oy |
Terapeutiskt utnyttjbar foerening.
|
|
FI864570A0
(fi)
|
1986-11-11 |
1986-11-11 |
Farmos Oy |
Terapeutiskt anvaendbar foerening.
|
|
GB2206880B
(en)
|
1987-07-16 |
1991-04-24 |
Farmos Oy |
Optical isomers of an imidazole derivative
|
|
GB2215206B
(en)
|
1988-02-29 |
1991-07-03 |
Farmos Oy |
4-substituted imidazole derivatives useful in perioperative care
|
|
US4994267A
(en)
|
1988-03-04 |
1991-02-19 |
Noven Pharmaceuticals, Inc. |
Transdermal acrylic multipolymer drug delivery system
|
|
US5656286A
(en)
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
|
US5217718A
(en)
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
|
US5124157A
(en)
|
1989-08-18 |
1992-06-23 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
|
FI894911A0
(fi)
|
1989-10-17 |
1989-10-17 |
Farmos Oy |
En terapeutiskt vaerdefull foerening.
|
|
US5304569A
(en)
|
1989-11-13 |
1994-04-19 |
Orion-Yhtyma Oy |
Compositions and their use in lowering intraocular pressure
|
|
US5447947A
(en)
|
1990-02-26 |
1995-09-05 |
Arc 1 |
Compositions and methods of treatment of sympathetically maintained pain
|
|
US5070084A
(en)
|
1990-02-26 |
1991-12-03 |
Campbell James N |
Treatment of sympathetically maintained pain
|
|
JP2849937B2
(ja)
|
1990-04-18 |
1999-01-27 |
日東電工株式会社 |
医療用貼付剤
|
|
GB9111732D0
(en)
|
1991-05-31 |
1991-07-24 |
Orion Yhtymae Oy |
The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
|
|
US5352456A
(en)
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
|
AU2782592A
(en)
|
1991-10-15 |
1993-05-21 |
Cygnus Therapeutic Systems |
Thermal enhancement of transdermal drug administration
|
|
US5459133A
(en)
|
1992-06-05 |
1995-10-17 |
Telor Ophthalmic Pharmaceuticals, Inc. |
Methods and products for treating presbyopia
|
|
GB2281206A
(en)
|
1993-08-25 |
1995-03-01 |
Orion Yhtymae Oy |
Use of dexmedetomidine
|
|
JPH0776526A
(ja)
|
1993-09-06 |
1995-03-20 |
Sansei Seiyaku Kk |
乳酸エステルを含有する経皮吸収製剤
|
|
JP2819236B2
(ja)
|
1994-05-06 |
1998-10-30 |
日東電工株式会社 |
経皮吸収製剤
|
|
GB2290964A
(en)
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
|
WO1996008229A2
(en)
|
1994-09-14 |
1996-03-21 |
Minnesota Mining And Manufacturing Company |
Matrix for transdermal drug delivery
|
|
US5635203A
(en)
|
1994-09-29 |
1997-06-03 |
Alza Corporation |
Transdermal device having decreased delamination
|
|
CN1101825C
(zh)
|
1995-03-31 |
2003-02-19 |
积水化学工业株式会社 |
制备溶剂型丙烯酸压敏粘合剂和医用压敏粘合剂的方法
|
|
CA2222133C
(en)
|
1995-06-07 |
2002-12-24 |
Cygnus, Inc. |
Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
|
|
US5891461A
(en)
|
1995-09-14 |
1999-04-06 |
Cygnus, Inc. |
Transdermal administration of olanzapine
|
|
GB9521680D0
(en)
|
1995-10-23 |
1996-01-03 |
Orion Yhtymo Oy |
New use of imidazole derivatives
|
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
IL135258A0
(en)
|
1997-09-26 |
2001-05-20 |
Noven Pharma |
Bioadhesive compositions and methods for topical administration of active agents
|
|
US6329369B1
(en)
|
1997-12-04 |
2001-12-11 |
Allergan Sales, Inc. |
Methods of treating pain and other conditions
|
|
US20020102291A1
(en)
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
|
US20020177592A1
(en)
|
1998-02-25 |
2002-11-28 |
Olney John W. |
Combination of adrenergic agonist and tricyclo-alkylamine for relieving chronic pain without adverse side effects
|
|
US20020068754A1
(en)
|
1998-02-25 |
2002-06-06 |
Olney John W. |
Combination of adrenergic agonist and aryl-cyclo-alkanolamine for relieving chronic pain without adverse side effects
|
|
US20020016319A1
(en)
|
1998-02-25 |
2002-02-07 |
Olney John W. |
Combined adamantane derivative and adrenergic agonist for relief of chronic pain without adverse side effects
|
|
AR015744A1
(es)
|
1998-04-01 |
2001-05-16 |
Orion Corp |
Uso de dexmedetomidina para sedacion en terapia intensiva
|
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
NZ510771A
(en)
|
1998-10-02 |
2003-08-29 |
3M Innovative Properties Co |
Mucosal originated drug delivery systems
|
|
ES2239466T3
(es)
|
1998-10-20 |
2005-09-16 |
Omeros Corporation |
Solucion de irrigacion y metodo de inhibicion del dolor y de la inflamacion.
|
|
US20030170195A1
(en)
|
2000-01-10 |
2003-09-11 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for drug delivery
|
|
PE20001396A1
(es)
|
1999-01-18 |
2000-12-23 |
Gruenenthal Chemie |
Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
|
|
DE19918106A1
(de)
|
1999-04-22 |
2000-10-26 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
|
|
GB9913677D0
(en)
|
1999-06-11 |
1999-08-11 |
Imperial College |
Formulation
|
|
DE19938823A1
(de)
|
1999-08-19 |
2001-02-22 |
Boehringer Ingelheim Pharma |
Medikamentöse Behandlung des Restless Leg Syndroms
|
|
WO2001047512A2
(en)
|
1999-12-08 |
2001-07-05 |
Fluoro Probe, Inc. |
Method for relieving pain associated with an internal disease site
|
|
AU2001243414B2
(en)
|
2000-03-10 |
2005-05-19 |
Durect Corporation |
Opioid formulations
|
|
AU7576501A
(en)
|
2000-03-28 |
2001-12-03 |
John W. Olney |
Combination of adrenergic agonist and nmda antagonist for relieving chronic painwithout adverse side effects
|
|
US20050042194A1
(en)
|
2000-05-11 |
2005-02-24 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
EP1155617A1
(en)
|
2000-05-17 |
2001-11-21 |
Rockwool International A/S |
Mineral wool plant substrate
|
|
DE10138722C5
(de)
|
2000-08-17 |
2017-05-24 |
Schaeffler Technologies AG & Co. KG |
Antriebsstrang
|
|
US7635488B2
(en)
|
2001-03-13 |
2009-12-22 |
Dbv Technologies |
Patches and uses thereof
|
|
FR2822049B1
(fr)
|
2001-03-13 |
2003-08-01 |
Dbv Medica 1 |
Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
|
|
FR2832311B1
(fr)
|
2001-11-21 |
2004-04-16 |
Besins Int Belgique |
Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
|
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
|
KR100511492B1
(ko)
|
2002-10-11 |
2005-08-31 |
주식회사 태평양 |
에페리손, 톨페리손 또는 그것들의 염을 포함하는경피흡수제제
|
|
US20040209907A1
(en)
|
2003-01-23 |
2004-10-21 |
Richard Franklin |
Formulation and methods for the treatment of thrombocythemia
|
|
DE10305137A1
(de)
|
2003-02-07 |
2004-08-26 |
Novosis Ag |
Transdermale therapeutische Abgabesysteme mit einem Butenolid
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
US7439241B2
(en)
|
2003-05-27 |
2008-10-21 |
Galderma Laboratories, Inc. |
Compounds, formulations, and methods for treating or preventing rosacea
|
|
US20050059664A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Novel methods for identifying improved, non-sedating alpha-2 agonists
|
|
US20050020600A1
(en)
|
2003-07-23 |
2005-01-27 |
Scherer Warren J. |
Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
|
|
JP4694967B2
(ja)
|
2003-07-31 |
2011-06-08 |
久光製薬株式会社 |
貼付剤
|
|
US20050058696A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
MXPA06002716A
(es)
|
2003-09-12 |
2006-06-06 |
Allergan Inc |
Metodos y composiciones para el tratamiento de dolor y otras condiciones mediadas por adrenergicos de alfa-2.
|
|
MEP23508A
(en)
|
2003-10-28 |
2010-06-10 |
Noven Pharma |
Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
|
|
JP4955543B2
(ja)
|
2004-05-25 |
2012-06-20 |
サンズローザ ファーマシューティカル ディヴェロップメント インコーポレイテッド |
炎症性皮膚疾患を治療又は予防するための化合物、製剤及び方法
|
|
CA2580694A1
(en)
|
2004-09-23 |
2006-03-30 |
Alexander Michalow |
Methods for regulating neurotransmitter systems by inducing counteradaptations
|
|
US20060166901A1
(en)
|
2005-01-03 |
2006-07-27 |
Yu Ruey J |
Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
|
|
US8114090B2
(en)
|
2005-01-06 |
2012-02-14 |
Kertzner Richard I |
Drill centering tool for removal of orthopedic plug
|
|
US20060210613A1
(en)
|
2005-03-15 |
2006-09-21 |
Carliss Richard D |
Therapeutic wound care product
|
|
US20070134310A1
(en)
|
2005-09-23 |
2007-06-14 |
Nedberge Diane E |
Transdermal risperidone delivery system
|
|
EP2308480B1
(en)
|
2005-09-23 |
2014-08-13 |
ALZA Corporation |
High Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
|
|
CA2614345C
(en)
|
2005-10-24 |
2013-01-08 |
Teikoku Pharma Usa, Inc. |
Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
|
|
TWI389709B
(zh)
|
2005-12-01 |
2013-03-21 |
Novartis Ag |
經皮治療系統
|
|
CN1994290B
(zh)
|
2006-01-04 |
2011-03-16 |
上海医药工业研究院 |
卡巴拉汀透皮贴剂及其制备方法
|
|
CN101395164A
(zh)
|
2006-01-10 |
2009-03-25 |
罗伊·J·于 |
N-(膦酰基烷基)-氨基酸、其衍生物和组合物以及使用方法
|
|
WO2007085556A2
(en)
|
2006-01-27 |
2007-08-02 |
F. Hoffmann-La Roche Ag |
Use of 4-imidazole derivatives for cns disorders
|
|
CA2643802A1
(en)
|
2006-02-27 |
2007-09-07 |
Alexander Michalow |
Methods for regulating neurotransmitter systems by inducing counteradaptations
|
|
WO2007103687A2
(en)
|
2006-03-01 |
2007-09-13 |
Tristrata, Inc. |
Composition and method for topical treatment of tar-responsive dermatological disorders
|
|
GB0611241D0
(en)
|
2006-06-07 |
2006-07-19 |
Daniolabs Ltd |
The treatment of increased sebum production
|
|
US20090258063A1
(en)
|
2006-09-11 |
2009-10-15 |
Sekisui Chemical Co., Ltd. |
Transdermal patch
|
|
US20090098191A1
(en)
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
|
JP5670196B2
(ja)
|
2007-11-16 |
2015-02-18 |
バイセプト セラピューティクス、インク． |
紫斑を治療する組成物および方法
|
|
US8011146B2
(en)
|
2007-12-19 |
2011-09-06 |
William Krause |
Blast-proof window and mullion system
|
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
|
JP5547065B2
(ja)
|
2008-05-15 |
2014-07-09 |
久光製薬株式会社 |
パロノセトロンを含有する経皮吸収製剤
|
|
US20110223204A1
(en)
|
2008-06-04 |
2011-09-15 |
Bradford J Duft |
Treatment of pain with gap junction modulation compounds
|
|
WO2010063030A2
(en)
|
2008-11-30 |
2010-06-03 |
Feigelson, Daniel |
Dermal application of vasoconstrictors
|
|
EP2330903A4
(en)
|
2008-07-28 |
2011-10-12 |
Endogenx Inc |
METHOD FOR TREATING PAIN USING AN ALPHA-2 ADRENEER AGONIST AND AN ENDOTHELINE ANTAGONIST
|
|
US20120156244A1
(en)
|
2008-08-01 |
2012-06-21 |
Alpha Synergy Development Inc. |
Nasal Compositions and Uses Thereof
|
|
US20110244058A1
(en)
|
2008-08-01 |
2011-10-06 |
Gerald Horn |
Compositions and methods for treatment of pulmonary diseases and conditions
|
|
US20100197694A1
(en)
|
2008-08-01 |
2010-08-05 |
Gerald Horn |
Compositions and methods for treatment of diseases and conditions with increased vascular permeability
|
|
US20110257188A1
(en)
|
2008-08-01 |
2011-10-20 |
Gerald Horn |
Compositions and methods for the treatment of nasal conditions
|
|
US20100202979A1
(en)
|
2008-08-01 |
2010-08-12 |
Gerald Horn |
Compositions and methods for treatment of pulmonary diseases and conditions
|
|
EP2165706A1
(en)
|
2008-09-18 |
2010-03-24 |
BioAlliance Pharma |
Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
|
|
US9308203B2
(en)
|
2008-10-01 |
2016-04-12 |
Taiwan Biotech Co., Ltd. |
Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
|
|
US8603497B2
(en)
|
2008-10-30 |
2013-12-10 |
National University Corporation Okayama University |
Composition for local anesthesia
|
|
US20120095104A1
(en)
|
2008-11-30 |
2012-04-19 |
Oron Zachar |
Use of vasoconstrictors
|
|
US20100196286A1
(en)
|
2008-12-01 |
2010-08-05 |
Armer Thomas A |
Inhalation delivery methods and devices
|
|
FR2942138A1
(fr)
|
2009-02-16 |
2010-08-20 |
Galderma Res & Dev |
Association de composes pour le traitement ou la prevention des affections dermatologiques
|
|
JP2012158521A
(ja)
|
2009-04-17 |
2012-08-23 |
Kureha Corp |
外用剤
|
|
RU2572692C2
(ru)
|
2009-05-15 |
2016-01-20 |
Рекро Фарма, Инк. |
Сублингвальные композиции дексмедетомидина и способы их применения
|
|
US8410140B2
(en)
|
2009-06-01 |
2013-04-02 |
The Regents Of The University Of Michigan |
Anesthetic methods and compositions
|
|
CN102753532B
(zh)
|
2009-12-09 |
2015-05-13 |
I-技术有限公司 |
美托咪定的制备方法
|
|
AU2011204315A1
(en)
*
|
2010-01-08 |
2012-08-02 |
Recro Pharma, Inc. |
Topical transdermal dexmedetomidine compositions and methods of use thereof
|
|
US9327105B2
(en)
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
US20130029989A1
(en)
|
2010-04-15 |
2013-01-31 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Topical treatments for pain
|
|
US9023788B2
(en)
|
2010-04-20 |
2015-05-05 |
New York University |
Methods compounds and pharmaceutical compositions for treating anxiety and mood disorders
|
|
US8563031B2
(en)
|
2010-05-27 |
2013-10-22 |
Absize, Inc. |
Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
|
|
CN103200944B
(zh)
|
2010-11-17 |
2016-05-04 |
赫克萨尔股份公司 |
包含丁丙诺啡的经皮治疗系统
|
|
TWI433904B
(zh)
|
2011-01-12 |
2014-04-11 |
Taiwan Biotech Co Ltd |
多奈哌齊經皮貼片
|
|
US20120202864A1
(en)
|
2011-02-03 |
2012-08-09 |
Alpha Synergy Development Inc. |
Compositions and Methods for Treatment of Glaucoma
|
|
US20120309720A1
(en)
|
2011-02-03 |
2012-12-06 |
Alpha Synergy Development Inc. |
Compositions and methods for treatment of glaucoma
|
|
EP2700401B1
(en)
|
2011-04-18 |
2020-01-15 |
Hisamitsu Pharmaceutical Co., Inc. |
Method for producing adhesive patch, and adhesive patch
|
|
US20130096170A1
(en)
*
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
|
PH12014500785A1
(en)
|
2011-10-19 |
2014-05-12 |
Galderma Sa |
Method for treating capillary hemangiomas
|
|
WO2013072763A2
(en)
|
2011-11-16 |
2013-05-23 |
Nometics Inc. |
Non-sensitizing transdermal clonidine patch
|
|
AU2012352528B9
(en)
|
2011-12-11 |
2017-11-02 |
Baudax Bio, Inc. |
Intranasal dexmedetomidine compositions and methods of use thereof
|
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
|
US20130211351A1
(en)
|
2012-01-31 |
2013-08-15 |
Gruenenthal Gmbh |
Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine
|
|
WO2013173317A1
(en)
|
2012-05-14 |
2013-11-21 |
Prospire, Llc |
TREATMENT OF OBSTRUCTIVE SLEEP APNEA WITH α2-ADRENERGIC RECEPTOR AGONISTS
|
|
BR112015004643A2
(pt)
|
2012-08-31 |
2017-07-04 |
Univ Midwestern |
métodos e composições para ressucitação hipotensiva
|
|
US20150366821A1
(en)
|
2012-11-13 |
2015-12-24 |
Ucl Business Plc |
Adrenergic agonists for use in treating liver damage
|
|
JP6370802B2
(ja)
|
2012-12-28 |
2018-08-08 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
持続性ブプレノルフィン経皮送達組成物およびそれの使用方法
|
|
KR101827980B1
(ko)
*
|
2013-10-07 |
2018-02-13 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
|
|
CA2924233C
(en)
|
2013-10-07 |
2018-10-23 |
Teikoku Pharma Usa, Inc. |
Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
|
|
CA2924190C
(en)
*
|
2013-10-07 |
2019-07-09 |
Teikoku Pharma Usa, Inc. |
Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
|
|
BR112016006848A2
(pt)
*
|
2013-10-07 |
2017-08-01 |
Teikoku Pharma Usa Inc |
métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
|
|
EP3054931B1
(en)
|
2013-10-07 |
2020-12-23 |
Teikoku Pharma USA, Inc. |
Transdermal delivery device for managing pain comprising dexmedetomidine transdermal compositions
|
|
US9974754B2
(en)
|
2013-12-18 |
2018-05-22 |
Maruishi Pharmaceutical Co., Ltd. |
Hydrous adhesive patch
|
|
WO2016105449A1
(en)
|
2014-12-22 |
2016-06-30 |
Seth Lederman |
Compounds for use as pain therapeutics
|
|
TWI764951B
(zh)
|
2016-10-31 |
2022-05-21 |
美商帝國製藥美國股份有限公司 |
用於處理疼痛之右美托咪啶經皮遞送裝置
|
|
TWI772807B
(zh)
|
2019-05-27 |
2022-08-01 |
日商救急藥品工業股份有限公司 |
外用製劑
|
|
EP4364729A4
(en)
|
2021-08-23 |
2024-11-27 |
Yichang Humanwell Pharmaceutical Co., Ltd. |
TRANSDERMAL COMPOSITION OF DEXMEDETOMIDINE, TRANSDERMAL PATCH AND METHOD OF PREPARATION AND USE THEREOF
|
|
CN116098876A
(zh)
|
2021-11-11 |
2023-05-12 |
北京泰德制药股份有限公司 |
一种右美托咪定透皮贴剂及其制备方法和应用
|
|
TW202519210A
(zh)
|
2023-09-05 |
2025-05-16 |
美商帝國製藥美國有限公司 |
用於治療疼痛之經皮遞送貼片
|